Objective: To evaluate the efficacy of gene therapy with the herpes simplex virus thymidine kinase (HSV TK) gene transference followed by ganciclovir (GCV) therapy in ovarian cancer.

• 目的：探讨单纯疱疹病毒胸苷激酶（HSV－TK）基因转染联合抗病毒药物羟基无环鸟苷（GCV）对人卵巢癌细胞系的杀伤效应。